Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1978 Apr;68(4):335–341. doi: 10.2105/ajph.68.4.335

Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators.

R Hoover, C Bain, P Cole, B MacMahon
PMCID: PMC1653930  PMID: 645979

Abstract

A questionnaire was mailed to 97,364 married women, aged 26--50, resident in Greater Boston in 1970, requesting information on lifetime oral contraceptive (OC) use, reproductive history, education, and hospitalization experience in 1969; 65,843 women responded. In 1973 a second questionnaire was mailed to 37,292 of these women, including all OC users and an equal number of non-users matched on age, parity, education, and town of residence. This questionnaire related to use of OCs, other female hormones, and the menopause. OC use was most strongly related to age, with a sixfold increase in use from the oldest women (of whom 10 per cent had used OCs at some time) to the youngest. Use was directly related to education and mobility and inversely related to parity. Reasons for beginning and ceasing use differed for women of different ages and educational attainment. Thus, use of OCs varies with social and reproductive characteristics that are risk indicators for many diseases. OC use was associated with increased risk of hospitalization for thromboembolic disease (risk ratio = 1.5, 95 per cent confidence limits 1.2, 3.2) and for mental illness, hyperthyroidism, hypertension, and cancer of the cervix. OC users were hospitalized for many non-life threatening conditions 20 to 40 per cent more frequently than were non-users.

Full text

PDF
335

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arthes F. G., Sartwell P. E., Lewison E. F. The pill, estrogens, and the breast. Epidemiologic aspects. Cancer. 1971 Dec;28(6):1391–1394. doi: 10.1002/1097-0142(197112)28:6<1391::aid-cncr2820280609>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  2. BOYD J. T., DOLL R. A STUDY OF THE AETIOLOGY OF CARCINOMA OF THE CERVIX UTERI. Br J Cancer. 1964 Sep;13:419–434. doi: 10.1038/bjc.1964.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carey H. M. Principles of oral contraception. 2. Side effects of oral contraceptives. Med J Aust. 1971 Dec 11;2(24):1242–1250. [PubMed] [Google Scholar]
  4. Cole P., Monson R. R., Haning H., Friedell G. H. Smoking and cancer f the lower urinary tract. N Engl J Med. 1971 Jan 21;284(3):129–134. doi: 10.1056/NEJM197101212840304. [DOI] [PubMed] [Google Scholar]
  5. Doll R. The long-term effects of steroid contraceptives. J Biosoc Sci. 1970 Oct;2(4):367–389. [PubMed] [Google Scholar]
  6. Dubrow H., Melamed M. R., Flehinger B. J., Kelisky R. P., Koss L. G. A study of factors affecting choice of contraceptives. Obstet Gynecol Surv. 1969 Jul;24(7 Pt 2):1012–1022. doi: 10.1097/00006254-196907001-00031. [DOI] [PubMed] [Google Scholar]
  7. Fasal E., Paffenbarger R. S., Jr Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst. 1975 Oct;55(4):767–773. doi: 10.1093/jnci/55.4.767. [DOI] [PubMed] [Google Scholar]
  8. Feldman J. G., Ogra S., Lippes J., Sultz H. A. Patterns and purposes of oral contraceptive use by economic status. Am J Public Health. 1971 Jun;61(6):1089–1095. doi: 10.2105/ajph.61.6.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldzieher J. W., Moses L. E., Averkin E., Scheel C., Taber B. Z. Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study. Am J Obstet Gynecol. 1971 Dec 15;111(8):1013–1020. doi: 10.1016/0002-9378(71)90096-2. [DOI] [PubMed] [Google Scholar]
  10. Herzberg B. N., Johnson A. L., Brown S. Depressive symptoms and oral contraceptives. Br Med J. 1970 Oct 17;4(5728):142–145. doi: 10.1136/bmj.4.5728.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kelsey J. L., Lindfors K. K., White C. A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use. Int J Epidemiol. 1974 Dec;3(4):333–340. doi: 10.1093/ije/3.4.333. [DOI] [PubMed] [Google Scholar]
  12. Laragh J. H. Oral contraceptives and hypertensive disease: a cybernetic overview. Circulation. 1970 Dec;42(6):983–985. doi: 10.1161/01.cir.42.6.983. [DOI] [PubMed] [Google Scholar]
  13. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  14. MacMahon B., Cole P., Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. doi: 10.1093/jnci/50.1.21. [DOI] [PubMed] [Google Scholar]
  15. Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
  16. Mann J. I., Inman W. H. Oral contraceptives and death from myocardial infarction. Br Med J. 1975 May 3;2(5965):245–248. doi: 10.1136/bmj.2.5965.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mann J. I., Vessey M. P., Thorogood M., Doll S. R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J. 1975 May 3;2(5965):241–245. doi: 10.1136/bmj.2.5965.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Melamed M. R., Koss L. G., Flehinger B. J., Kelisky R. P., Dubrow H. Prevalence rates of uterine cervical carcinoma in situ for women using the diaphragm or contraceptive oral steroids. Br Med J. 1969 Jul 26;3(5664):195–200. doi: 10.1136/bmj.3.5664.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme. Lancet. 1973 Jun 23;1(7817):1399–1404. [PubMed] [Google Scholar]
  20. Ory H., Cole P., MacMahon B., Hoover R. Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med. 1976 Feb 19;294(8):419–422. doi: 10.1056/NEJM197602192940804. [DOI] [PubMed] [Google Scholar]
  21. Rotkin I. D. Epidemiology of cancer of the cervix. 3. Sexual characteristics of a cervical cancer population. Am J Public Health Nations Health. 1967 May;57(5):815–829. doi: 10.2105/ajph.57.5.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am J Epidemiol. 1969 Nov;90(5):365–380. doi: 10.1093/oxfordjournals.aje.a121082. [DOI] [PubMed] [Google Scholar]
  23. Saruta T., Saade G. A., Kaplan N. M. A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release. Arch Intern Med. 1970 Oct;126(4):621–626. [PubMed] [Google Scholar]
  24. Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
  25. Stern E., Clark V. A., Coffelt C. F. Contraceptive methods: selective factors in a study of dysplasia of the cervix. Am J Public Health. 1971 Mar;61(3):553–558. doi: 10.2105/ajph.61.3.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tobon H. Malignant hypertension, uremia and hemolytic anemia in a patient on oral contraceptives. Obstet Gynecol. 1972 Nov;40(5):681–685. [PubMed] [Google Scholar]
  27. Tyson J. E. Oral contraception and elevated blood pressure. Am J Obstet Gynecol. 1968 Mar 15;100(6):875–877. doi: 10.1016/s0002-9378(15)33594-8. [DOI] [PubMed] [Google Scholar]
  28. Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J. 1968 Apr 27;2(5599):199–205. doi: 10.1136/bmj.2.5599.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Vessey M. P., Doll R., Peto R., Redman G. Characteristics of women using different methods of contraception--some preliminary findings from a prospective study. Int J Epidemiol. 1972 Summer;1(2):119–123. doi: 10.1093/ije/1.2.119. [DOI] [PubMed] [Google Scholar]
  30. Vessey M. P., Doll R., Sutton P. M. Oral contraceptives and breast neoplasia: a retrospective study. Br Med J. 1972 Sep 23;3(5829):719–724. doi: 10.1136/bmj.3.5829.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Weir R. J., Briggs E., Mack A., Naismith L., Taylor L., Wilson E. Blood pressure in women taking oral contraceptives. Br Med J. 1974 Mar 23;1(5907):533–535. doi: 10.1136/bmj.1.5907.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Weiss N. S., Szekely D. R., Austin D. F. Increasing incidence of endometrial cancer in the United States. N Engl J Med. 1976 Jun 3;294(23):1259–1262. doi: 10.1056/NEJM197606032942303. [DOI] [PubMed] [Google Scholar]
  33. Westoff C. F., Bumpass L., Ryder N. B. Oral contraception, coital frequency, and the time required to conceive. Soc Biol. 1969 Mar;16(1):1–10. doi: 10.1080/19485565.1969.9987794. [DOI] [PubMed] [Google Scholar]
  34. Westoff C. F., Ryder N. B. Experience with oral contraception in the United States, 1960-1965. Clin Obstet Gynecol. 1968 Sep;11(3):734–752. doi: 10.1097/00003081-196811030-00008. [DOI] [PubMed] [Google Scholar]
  35. Westoff C. F. The modernization of U.S. contraceptive practice. Fam Plann Perspect. 1972 Jul;4(3):9–12. [PubMed] [Google Scholar]
  36. Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES